Table 5–2: United States – Pediatric Flu Vaccine Price, 2017 – 2018 Table 5–3: United States – Adult Flu Vaccine Price, 2017 – 2018 Table 5–4: United States – Flu Vaccine Production, Supply, and Allocation Table 5–5: Total Percentage of Flu Vaccines Released by Week,2016 – 2017 Table 5–6: Total Percentage of Flu Vaccines Released by Week,2015 – 2016 Table 5–7: Total Percentage of Flu Vaccines Released by Week,2014 – 2015 Table 5–8: Adjusted Vaccine Effectiveness Estimates for Flu Seasons, 2005 – 2016 Table 5–9: Influenza Virus Testing Methods Table 5–10: Distribution of Flu Vaccination Table 6–1: United States – Simplified Regulatory Pathway from Preclinical to the Marketing Authorization Table 7–1: Flu Vaccine Market – Merger & Acquisitions (Million US$),2003 – 2017 Table 7–2: Flu Vaccine Market – Collaborations Deal,2007 – 2017 Table 7–3: Flu Vaccine Market – Licensing Agreement,2007 – 2016 Table 7–4: Flu Vaccine Market – Exclusive Agreement,2009 – 2016 Table 7–5: Flu Vaccine Market – Distribution Agreement,2005 – 2016Figure 2 1: United States – Flu Vaccine Market (Million US$),2010 – 2016 Figure 2 2: United States – Forecast for Flu Vaccine Market (Million US$),2017 – 2024 Figure 3 1: United States – Total Number of Persons Vaccinated(Thousand), 2010 – 2016 Figure 3 2: United States – Forecast for Total Number of Persons Vaccinated(Thousand), 2017 – 2024 Figure 3 3: United States – Number of Children Vaccinated(Thousand),2010 – 2016 Figure 3 4: United States – Forecast for Number of Children Vaccinated(Thousand),2017 – 2024 Figure 3 5: United States – Number of Adults Vaccinated(Thousand),2010 – 2016 Figure 3 6: United States – Forecast for Number of Adults Vaccinated(Thousand),2017 – 2024 Figure 5 1: United States – Flu Vaccine Doses Distributed, By Season(Million),2010 – 2017 Figure 10 1: Sanofi Pasteur – Flu Vaccine Net Sales (Million US$),2011 – 2016 Figure 10 2: Sanofi Pasteur – Forecast for Flu Vaccine Net Sales (Million US$),2017 – 2024 Figure 10 3: GSK – Flu Vaccine Net Sales (Million US$),2011 – 2016 Figure 10 4: GSK – Forecast for Flu Vaccine Net Sales (Million US$),2017 – 2024 |
|